Dr. Ning is interested in the interaction between chronic viral infections and the host innate immune system in carcinogenesis, with the focus on the type I interferons-mediated innate immune system, DNA damage response, autophagy, and oxidative stress. The long-term goal of these studies is to identify molecular targets for cancer immunotherapeutic and antiviral therapeutic applications.